Benzinga | Aug 5, 2021 04:52PM EDT

Assertio Therapeutics Q2 EPS $(0.32) Up From $(1.40) YoY, Sales $24.83M Beat $24.26M Estimate

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly losses of $(0.32) per share. This is a 77.14 percent increase over losses of $(1.40) per share from the same period last year. The company reported quarterly sales of $24.83 million which beat the analyst consensus estimate of $24.26 million by 2.35 percent. This is a 20.44 percent increase over sales of $20.62 million the same period last year.